48. Jahrestagung und 26. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH)

Adolph, TE

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Lipocalin2 protects from severe inflammation in IL-10 knockout mice

Aichelburg, M

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

Aichelburg, MC

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Aigner, E

Natural course of subjects with elevated liver enzymes and normal liver histology

A distinct profile of Lyso-Phosphatidylcholines and amino acids characterizes NAFLD in lean subjects

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women

Albinni, S

Transorale Schwellenspaltung bei Zenker'schem Hypopharynxdivertikel

Allgaier, H

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Al-Zoairy, R

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C virus

Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria

Liefert die Aspiration von Galle bei der ERCP einen Mikrobiologisch & Klinisch validen Befund?

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Ambrosch, S

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Angermayr, B

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Anzinger, M

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Asselah, T

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Auer, A

Österreich-adaptierte FODMAP-arme Diät bei Reizdarmsyndrom: Pilotstudie

Austerlitz, T

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Baghdasaryan, A

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Bale, R

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Bamberger, T

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Bashir, K

Azathioprine versus Mycophenolate Mofetil in combination with anti-TNF alpha agents in the management of Crohn's Disease

Bashir, M

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Bauer, B

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Bauer, D

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Beinhardt, S

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Interferon-free regimens overcome the effect of portal hypertension on virologic response

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C virus

Usefulness of interferon Lambda-4, HLA Class II Polymorphysims and Killer-Immunglobuline-Like Recptor-2DL3:C1/C1 to predict spontaneous clearance of acute Hepatitis C virus infection

Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Berger, A

How many patients undergoing surgery for perianal abscess or fistula receive a diagnosis of IBD during follow-up?

Berghold, A

How many patients undergoing surgery for perianal abscess or fistula receive a diagnosis of IBD during follow-up?

Berr, F

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Selektive ultraschallgesteuerte percutane transhepatische Cholangiografie und Drainage

Bersuch, LA

Häufigkeit und Differentialdiagnosen einer erhöhten alkalischen Phosphatase bei PatientInnen mit CED an der Universitätsklinik für Innere Medizin Graz

Betz, C

Österreich-adaptierte FODMAP-arme Diät bei Reizdarmsyndrom: Pilotstudie

Beyreis, M

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Bichler, A

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Bischof, M

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Bjarnason, I

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Blesl, A

Entzündlicher IgG4-positiver Pseudotumor der Lunge bei primär sklerosierender Cholangitis (PSC)

Bodlaj, G

Pyoderma gangraenosum als seltene Komplikation eines M. Crohn

Pilotstudie: Knochendichte und Knochenmikroarchitektur bei Patienten mit Leberzirrhose

Bognar, B

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Bösing, M

Long-term outcome of TNFα antibody treatment in patients with IBD: a retrospective single center study over 14 years

Bota, S

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Bretterklieber, C

Helicobacter pylori resistance in Southern Austria

Breuer, R

The relationship between gastric emptying and the postprandial exocrine pancreatic function measured by 11C-methionine PET-CT.

Britto-Arias, M

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Brusilovskaya, K

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Bucsics, T

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Buder, R

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Buggisch, P

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Bunte, C

Tako Tsubo Kardiomyopathie unter TNF alpha Therapie

Buti, M

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Cejna, M

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Claudel, T

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

NorUDCA improves liver injury and glucose sensitivity in a mouse model of obesity and steatosis

Craxi, A

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Dabsch, S

Autoimmune gastritis is common in patients with iron deficiency – Non-invasive evaluation of iron deficiency aside guideline recommendations

Danzinger, D

Erste Erfahrungen mit einer interdisziplinären Station für chronisch entzündliche Darmerkrankungen

Datz, C

Natural course of subjects with elevated liver enzymes and normal liver histology

A distinct profile of Lyso-Phosphatidylcholines and amino acids characterizes NAFLD in lean subjects

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women

Dejaco, C

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Diermayr, M

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Di Fazio, P

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Dinkhauser, P

Adenokarzinome des Dünndarms – eine retrospektive monozentrische Analyse

Dolak, W

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Endoscopic unroofing is effective for diagnosis and therapy of gastric submucosal tumors: A retrospective study including follow-up

Dorn, L

Transferrin als unabhängiger Prädiktor für das Überleben bei Patienten mit Leberzirrhose

Douschan, P

Serum bile acids in cirrhosis depend on aetiology

Durchschein, F

Einfluss der Brust- und Bauchatmung auf den Druck des unteren Ösophagussphinkters

Morbus Whipple: Aktuelle Aspekte anhand eines Fallberichts

Serum bile acids in cirrhosis depend on aetiology

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Therapierelevanz des H2-Atemtests macht zusätzliche Symptommessung erforderlich

Prävalenz der Trehalose Malabsorption bei PatientInnen mit Blähungen und Bauchschmerzen

Dzirlo, L

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Eckhard, G

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Eder, M

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Eder, S

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Eder, SK

A distinct profile of Lyso-Phosphatidylcholines and amino acids characterizes NAFLD in lean subjects

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Eherer, A

Einfluss der Brust- und Bauchatmung auf den Druck des unteren Ösophagussphinkters

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Eichhorn, P

Resistenzbestimmung bei Helicobacter-Pylori im Rahmen durchgeführter Gastroskopien im LK Amstetten in den Jahren von 2009 bis 2014

Eigner, W

Azathioprine versus Mycophenolate Mofetil in combination with anti-TNF alpha agents in the management of Crohn's Disease

Eltschka, B

Transorale Schwellenspaltung bei Zenker'schem Hypopharynxdivertikel

Enko, D

Carbohydrate malabsorption and carbohydrate-specific small intestinal bacterial overgrowth: diagnostic approach and overlap

Enrich, B

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Erhart, F

Resistenzbestimmung bei Helicobacter-Pylori im Rahmen durchgeführter Gastroskopien im LK Amstetten in den Jahren von 2009 bis 2014

Evstatiev, R

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Fasching, E

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Fauler, G

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Serum bile acids in cirrhosis depend on aetiology

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Feichtenschlager, T

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Felder, T

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Felder, TK

A distinct profile of Lyso-Phosphatidylcholines and amino acids characterizes NAFLD in lean subjects

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Feldman, A

A distinct profile of Lyso-Phosphatidylcholines and amino acids characterizes NAFLD in lean subjects

Feldner-Busztin, M

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Feng, Q

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Ferenci, P

Natural course of subjects with elevated liver enzymes and normal liver histology

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Interferon-free regimens overcome the effect of portal hypertension on virologic response

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Ferlitsch, A

Interferon-free regimens overcome the effect of portal hypertension on virologic response

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Ferlitsch, M

Endoscopists with lowest sedation rates detect more colorectal adenomas in colonoscopy than those most frequently using sedation

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Low ADR is associated with poor adherence to post polypectomy surveillance guidelines

Fickert, P

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Seneszenzstimuli und Hypoxie induzieren LOXL2 und HIF1alpha Expression und führen zur Repression von E-Cadherin in Gallengangsepithelzellen

Entzündlicher IgG4-positiver Pseudotumor der Lunge bei primär sklerosierender Cholangitis (PSC)

Differentielle Effekte von Gallensäuren auf Tubulus- und Sammelrohrepithelzellen

Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber

Serum bile acids in cirrhosis depend on aetiology

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Häufigkeit und Differentialdiagnosen einer erhöhten alkalischen Phosphatase bei PatientInnen mit CED an der Universitätsklinik für Innere Medizin Graz

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Fida, S

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Finkenstedt, A

Transferrin als unabhängiger Prädiktor für das Überleben bei Patienten mit Leberzirrhose

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Flatz, T

Oesophagusperforation/-ruptur: Stentung als primäre Therapieoption

Fogli, M

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Foster, GR

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Frank, J

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Franke, A

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Freissmuth, C

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Interferon-free regimens overcome the effect of portal hypertension on virologic response

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C virus

Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Freund, M

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Frick, A

Oxidative stress is a driver of chromosomal instability and tumorigenesis in IL-10KO mice

Friesenbichler, P

Das Bouveret-Syndrom als seltene Ursache eines Gastric-outlet-Syndroms

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Selektive ultraschallgesteuerte percutane transhepatische Cholangiografie und Drainage

Fröhlich-Reiterer, E

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Fuchs, C

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Fuchs, CD

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing Cholangitis

Fuchssteiner, H

Retrospektive Outcomeanalyse von Colitis ulcerosa (CU) Patienten mit schwerem, steroidrefraktärem Schub

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Fuhrmann, V

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Gajdošík, M

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Garnys, L

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

Gartner, J

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Gasche, A

Autoimmune gastritis is common in patients with iron deficiency – Non-invasive evaluation of iron deficiency aside guideline recommendations

Gasche, C

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Autoimmune gastritis is common in patients with iron deficiency – Non-invasive evaluation of iron deficiency aside guideline recommendations

Gerner, R

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Gerner, RR

Lipocalin2 protects from severe inflammation in IL-10 knockout mice

Akkermansia muciniphila protects from experimental alcoholic liver disease

Gessl, I

Endoscopists with lowest sedation rates detect more colorectal adenomas in colonoscopy than those most frequently using sedation

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Low ADR is associated with poor adherence to post polypectomy surveillance guidelines

Glänzer, D

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Glodny, B

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Goliasch, G

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Gorkiewicz, G

Morbus Whipple: Aktuelle Aspekte anhand eines Fallberichts

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Grabherr, F

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Grabherr, FS

Akkermansia muciniphila protects from experimental alcoholic liver disease

Grabmeier-Pfistershammer, K

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

Grabner, S

Helicobacter pylori resistance in Southern Austria

Graffner, H

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Grander, C

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Akkermansia muciniphila protects from experimental alcoholic liver disease

Graziadei, I

Liefert die Aspiration von Galle bei der ERCP einen Mikrobiologisch & Klinisch validen Befund?

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Griesmacher, A

Transferrin als unabhängiger Prädiktor für das Überleben bei Patienten mit Leberzirrhose

Grimaldi, M

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Gröchenig, H

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Gschwantler, M

Efficacy of interferon-free all-oral regimens in the treatment of chronic Hepatitis C outside from clinical trials – a “real life experience”

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Access to reimbursement of interferon-free all-oral regimens for patients with chronic Hepatitis C in Austria

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Gumhold, J

Seneszenzstimuli und Hypoxie induzieren LOXL2 und HIF1alpha Expression und führen zur Repression von E-Cadherin in Gallengangsepithelzellen

Gutic, E

Efficacy of interferon-free all-oral regimens in the treatment of chronic Hepatitis C outside from clinical trials – a “real life experience”

Access to reimbursement of interferon-free all-oral regimens for patients with chronic Hepatitis C in Austria

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Haas, T

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Häfner, M

Erste Erfahrungen mit einer interdisziplinären Station für chronisch entzündliche Darmerkrankungen

Behandlung von Präkanzerosen und Frühkarzinomen des oberen Gastrointestinaltrakts mittels endoskopischer Submukosadissektion – Behandlungsergebnisse der letzten 5 Jahre im KH St. Elisabeth Wien

Fokale Läsionen bei Barrettösophagus: Ergebnisse endoskopischer Interventionen im KH St. Elisabeth

Halilbasic, E

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Haltmayer, H

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Halwachs-Baumann, G

Carbohydrate malabsorption and carbohydrate-specific small intestinal bacterial overgrowth: diagnostic approach and overlap

Hambruch, E

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

Hamethner, S

Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria

Hametner, S

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Hammer, HF

Österreich-adaptierte FODMAP-arme Diät bei Reizdarmsyndrom: Pilotstudie

Therapierelevanz des H2-Atemtests macht zusätzliche Symptommessung erforderlich

Prävalenz der Trehalose Malabsorption bei PatientInnen mit Blähungen und Bauchschmerzen

Hammer, J

Österreich-adaptierte FODMAP-arme Diät bei Reizdarmsyndrom: Pilotstudie

Spontane Ösophagusperforation bei Vater und Sohn: ein 25- bzw. 10 Jahre Follow-up

Hammer, K

Spontane Ösophagusperforation bei Vater und Sohn: ein 25- bzw. 10 Jahre Follow-up

Harbaum, L

Grading lymph node metastasis – a feasible approach for prognostication of stage III colorectal cancer patients

Haschka, D

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Haufe, H

Natural course of subjects with elevated liver enzymes and normal liver histology

Haybaeck, J

Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors – A TMA based Study

Hayden, H

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Heckmann, M

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Heiler, K

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Heinemann, Á

DP2 Rezeptor-Antagonismus schützt vor entzündlichen Darmerkrankungen: proinflammatorische Rolle von Eosinophilen

Heinze, G

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Hell, M

Selektive ultraschallgesteuerte percutane transhepatische Cholangiografie und Drainage

Hellmich, B

Efficacy of interferon-free all-oral regimens in the treatment of chronic Hepatitis C outside from clinical trials – a “real life experience”

Access to reimbursement of interferon-free all-oral regimens for patients with chronic Hepatitis C in Austria

Henninger, B

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Höbling, W

Adenokarzinome des Dünndarms – eine retrospektive monozentrische Analyse

Hofer, H

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Interferon-free regimens overcome the effect of portal hypertension on virologic response

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Hoffmann, K

Einfluss der Brust- und Bauchatmung auf den Druck des unteren Ösophagussphinkters

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Hoffmann, KM

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Högenauer, C

Einfluss der Brust- und Bauchatmung auf den Druck des unteren Ösophagussphinkters

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Long-term outcome of TNFα antibody treatment in patients with IBD: a retrospective single center study over 14 years

Morbus Whipple: Aktuelle Aspekte anhand eines Fallberichts

DP2 Rezeptor-Antagonismus schützt vor entzündlichen Darmerkrankungen: proinflammatorische Rolle von Eosinophilen

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Loss of Response to TNF-α blockers is associated with Levels of Drug and Antidrug Antibodies in IBD patients

Helicobacter pylori resistance in Southern Austria

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Holzmann, H

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

Horvath, A

Endotoxinmessung bei Leberzirrhose: Ein Methodenvergleich

Serum bile acids in cirrhosis depend on aetiology

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Horvatits, T

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Huber, V

Adenokarzinome des Dünndarms – eine retrospektive monozentrische Analyse

Huber-Schönauer, U

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women

Hubner, D

Adenokarzinome des Dünndarms – eine retrospektive monozentrische Analyse

Hucke, F

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Hufschmidt, M

Oesophagusperforation/-ruptur: Stentung als primäre Therapieoption

Illig, R

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Jahnel, J

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Loss of Response to TNF-α blockers is associated with Levels of Drug and Antidrug Antibodies in IBD patients

Janecke, A

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Jasser-Nitsche, H

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Jeschek, P

Endoscopists with lowest sedation rates detect more colorectal adenomas in colonoscopy than those most frequently using sedation

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Jimenez, K

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Jonas, M

Gesundheitsökonomische Auswirkungen eines qualitätsgesicherten Vorsorge-Koloskopie-Programms am Beispiel der Vorarlberger Vorsorge-Koloskopie 2007 – 2013

Jovanovic, Z

Transorale Schwellenspaltung bei Zenker'schem Hypopharynxdivertikel

Karanikas, G

The relationship between gastric emptying and the postprandial exocrine pancreatic function measured by 11C-methionine PET-CT.

Karnel, F

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Karner, J

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Karpi, A

Efficacy of interferon-free all-oral regimens in the treatment of chronic Hepatitis C outside from clinical trials – a “real life experience”

Access to reimbursement of interferon-free all-oral regimens for patients with chronic Hepatitis C in Austria

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Kashofer, K

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Kazianka, L

The relationship between gastric emptying and the postprandial exocrine pancreatic function measured by 11C-methionine PET-CT.

Keil, F

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Kelz, F

Loss of Response to TNF-α blockers is associated with Levels of Drug and Antidrug Antibodies in IBD patients

Khare, V

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Kienbacher, C

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Kienbauer, M

Retrospektive Outcomeanalyse von Colitis ulcerosa (CU) Patienten mit schwerem, steroidrefraktärem Schub

Kiesslich, T

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Kimbacher, C

Carbohydrate malabsorption and carbohydrate-specific small intestinal bacterial overgrowth: diagnostic approach and overlap

Kirchgatterer, A

Tako Tsubo Kardiomyopathie unter TNF alpha Therapie

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Kleber, G

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Klimscha, S

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Klymiuk, I

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Knoflach, P

Adenokarzinome des Dünndarms – eine retrospektive monozentrische Analyse

Koch, R

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Kocijan, R

Sclerostin levels and changes in bone metabolism after bariatric surgery

Korak, W

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Kornprat, P

How many patients undergoing surgery for perianal abscess or fistula receive a diagnosis of IBD during follow-up?

Grading lymph node metastasis – a feasible approach for prognostication of stage III colorectal cancer patients

Kozbial, K

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Interferon-free regimens overcome the effect of portal hypertension on virologic response

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C virus

Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Krause, R

Morbus Whipple: Aktuelle Aspekte anhand eines Fallberichts

Helicobacter pylori resistance in Southern Austria

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Kremoser, C

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

Kriegshäuser, G

Carbohydrate malabsorption and carbohydrate-specific small intestinal bacterial overgrowth: diagnostic approach and overlap

Krnjic, A

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Krones, E

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Entzündlicher IgG4-positiver Pseudotumor der Lunge bei primär sklerosierender Cholangitis (PSC)

Differentielle Effekte von Gallensäuren auf Tubulus- und Sammelrohrepithelzellen

Serum bile acids in cirrhosis depend on aetiology

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Häufigkeit und Differentialdiagnosen einer erhöhten alkalischen Phosphatase bei PatientInnen mit CED an der Universitätsklinik für Innere Medizin Graz

Krššák, M

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Kump, P

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Long-term outcome of TNFα antibody treatment in patients with IBD: a retrospective single center study over 14 years

Morbus Whipple: Aktuelle Aspekte anhand eines Fallberichts

Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors – A TMA based Study

Kump, PK

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Lackner, C

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Laferl, H

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Efficacy and Safety of Telbivudine as First-Line Therapy in Patients With Compensated Chronic Hepatitis B

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Lamprecht, M

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Lanas, A

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Lang, M

Iron (III)-Sodium-EDTA, as used for food fortification, aggravates intestinal inflammation and drives tumorigenesis in mouse models of colitis-associated cancer

Langner, C

Grading lymph node metastasis – a feasible approach for prognostication of stage III colorectal cancer patients

Lassnig, E

Tako Tsubo Kardiomyopathie unter TNF alpha Therapie

Leber, B

Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF

Endotoxinmessung bei Leberzirrhose: Ein Methodenvergleich

Serum bile acids in cirrhosis depend on aetiology

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Lederer, D

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Leitner, E

Helicobacter pylori resistance in Southern Austria

Lemberger, U

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Lemesch, S

Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF

Serum bile acids in cirrhosis depend on aetiology

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Lenz, O

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Lichtmannegger, L

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Akkermansia muciniphila protects from experimental alcoholic liver disease

Lin, H

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Lindtner, RA

Grading lymph node metastasis – a feasible approach for prognostication of stage III colorectal cancer patients

Lipp, R

Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors – A TMA based Study

Lonjon-Domanec, I

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Luck, H

Resistenzbestimmung bei Helicobacter-Pylori im Rahmen durchgeführter Gastroskopien im LK Amstetten in den Jahren von 2009 bis 2014

Ludwiczek, O

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Luger, A

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Lutz, M

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Madl, C

Klinischer Vergleich der Detektionsrate der 360 ° Dünndarmkapsel mit front view Dünndarmkapsel- Systemen hinsichtlich Schleimhautläsionen bei M. Crohn und Eisenmangelanämie

Maieron, A

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Mandorfer, M

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Interferon-free regimens overcome the effect of portal hypertension on virologic response

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C virus

Usefulness of interferon Lambda-4, HLA Class II Polymorphysims and Killer-Immunglobuline-Like Recptor-2DL3:C1/C1 to predict spontaneous clearance of acute Hepatitis C virus infection

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Marchart, K

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Marculescu, R

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Marschall, H

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber

Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing Cholangitis

Marshall, D

Seneszenzstimuli und Hypoxie induzieren LOXL2 und HIF1alpha Expression und führen zur Repression von E-Cadherin in Gallengangsepithelzellen

Marterer, C

Sclerostin levels and changes in bone metabolism after bariatric surgery

Matzneller, P

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Mayer, A

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Mayr, C

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Messner, Z

Pyoderma gangraenosum als seltene Komplikation eines M. Crohn

Miehsler, W

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Miholic, J

The relationship between gastric emptying and the postprandial exocrine pancreatic function measured by 11C-methionine PET-CT.

Moreno, C

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Mörth, E

Helicobacter pylori resistance in Southern Austria

Moschen, AR

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Lipocalin2 protects from severe inflammation in IL-10 knockout mice

Akkermansia muciniphila protects from experimental alcoholic liver disease

Moser, P

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Moser, S

Efficacy of interferon-free all-oral regimens in the treatment of chronic Hepatitis C outside from clinical trials – a “real life experience”

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Access to reimbursement of interferon-free all-oral regimens for patients with chronic Hepatitis C in Austria

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Much, N

Erste Erfahrungen mit einer interdisziplinären Station für chronisch entzündliche Darmerkrankungen

Mülleder, K

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Munda, P

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Muschitz, C

Pilotstudie: Knochendichte und Knochenmikroarchitektur bei Patienten mit Leberzirrhose

Sclerostin levels and changes in bone metabolism after bariatric surgery

Muschitz, GK

Sclerostin levels and changes in bone metabolism after bariatric surgery

Nachbaur, K

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Neureiter, D

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Nia, A

Pilotstudie: Knochendichte und Knochenmikroarchitektur bei Patienten mit Leberzirrhose

Niederseer, D

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women

Nitzlader, M

Efficacy and Safety of Telbivudine as First-Line Therapy in Patients With Compensated Chronic Hepatitis B

Novacek, G

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Orth-Höller, D

Liefert die Aspiration von Galle bei der ERCP einen Mikrobiologisch & Klinisch validen Befund?

Oswald, S

Pyoderma gangraenosum als seltene Komplikation eines M. Crohn

Oyama, T

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Pablik, E

Low ADR is associated with poor adherence to post polypectomy surveillance guidelines

Pachofszky, T

Klinischer Vergleich der Detektionsrate der 360 ° Dünndarmkapsel mit front view Dünndarmkapsel- Systemen hinsichtlich Schleimhautläsionen bei M. Crohn und Eisenmangelanämie

Pail, E

Österreich-adaptierte FODMAP-arme Diät bei Reizdarmsyndrom: Pilotstudie

Panzitt, K

Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber

Papay, P

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Papula, C

Therapierelevanz des H2-Atemtests macht zusätzliche Symptommessung erforderlich

Parsche, P

Helicobacter pylori resistance in Southern Austria

Patsch, W

Natural course of subjects with elevated liver enzymes and normal liver histology

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women

Paumgartner, G

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing Cholangitis

Pavek, J

Morbus Whipple: Aktuelle Aspekte anhand eines Fallberichts

Helicobacter pylori resistance in Southern Austria

Payer, B

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

Payer, BA

Usefulness of interferon Lambda-4, HLA Class II Polymorphysims and Killer-Immunglobuline-Like Recptor-2DL3:C1/C1 to predict spontaneous clearance of acute Hepatitis C virus infection

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

Payerl, D

Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF

Peck-Radosavljevic, M

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Interferon-free regimens overcome the effect of portal hypertension on virologic response

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Peters, P

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Petersen, B

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Peterson, J

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Petritsch, W

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Long-term outcome of TNFα antibody treatment in patients with IBD: a retrospective single center study over 14 years

How many patients undergoing surgery for perianal abscess or fistula receive a diagnosis of IBD during follow-up?

Loss of Response to TNF-α blockers is associated with Levels of Drug and Antidrug Antibodies in IBD patients

Pfister, A

Lipocalin2 protects from severe inflammation in IL-10 knockout mice

Pfisterer, N

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Pichler, M

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Pieber, T

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Pietschmann, P

Sclerostin levels and changes in bone metabolism after bariatric surgery

Pirich, C

Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women

Plamenig, D

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Plankensteiner, G

Efficacy and Safety of Telbivudine as First-Line Therapy in Patients With Compensated Chronic Hepatitis B

Platzer, R

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Plieschnegger, W

Helicobacter pylori resistance in Southern Austria

Pokieser, P

Transorale Schwellenspaltung bei Zenker'schem Hypopharynxdivertikel

Pollheimer, M

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Pollheimer, MJ

Seneszenzstimuli und Hypoxie induzieren LOXL2 und HIF1alpha Expression und führen zur Repression von E-Cadherin in Gallengangsepithelzellen

Entzündlicher IgG4-positiver Pseudotumor der Lunge bei primär sklerosierender Cholangitis (PSC)

Grading lymph node metastasis – a feasible approach for prognostication of stage III colorectal cancer patients

Portenkirchner, M

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Primas, C

Azathioprine versus Mycophenolate Mofetil in combination with anti-TNF alpha agents in the management of Crohn's Disease

Prokop, W

Transferrin als unabhängiger Prädiktor für das Überleben bei Patienten mit Leberzirrhose

Purevsambuu, T

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Püspök, A

Endoscopic unroofing is effective for diagnosis and therapy of gastric submucosal tumors: A retrospective study including follow-up

Racedo, S

Seneszenzstimuli und Hypoxie induzieren LOXL2 und HIF1alpha Expression und führen zur Repression von E-Cadherin in Gallengangsepithelzellen

Racedo, SM

Differentielle Effekte von Gallensäuren auf Tubulus- und Sammelrohrepithelzellen

Radlspöck, W

Transorale Schwellenspaltung bei Zenker'schem Hypopharynxdivertikel

Radnai, B

DP2 Rezeptor-Antagonismus schützt vor entzündlichen Darmerkrankungen: proinflammatorische Rolle von Eosinophilen

Rahbar Nia, A

Sclerostin levels and changes in bone metabolism after bariatric surgery

Rainer, F

Entzündlicher IgG4-positiver Pseudotumor der Lunge bei primär sklerosierender Cholangitis (PSC)

Rast, C

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Ravasi, G

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Reiberger, T

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Interferon-free regimens overcome the effect of portal hypertension on virologic response

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Reichmayr, M

Hamm-Sign: ein neues endoskopisches Zeichen in der Helicobacter-pylori Diagnostik

Reicht, G

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Helicobacter pylori resistance in Southern Austria

Reif-Breitwieser, J

Prävalenz der Trehalose Malabsorption bei PatientInnen mit Blähungen und Bauchschmerzen

Rein, P

Gesundheitsökonomische Auswirkungen eines qualitätsgesicherten Vorsorge-Koloskopie-Programms am Beispiel der Vorarlberger Vorsorge-Koloskopie 2007 – 2013

Reisinger, M

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Reiter, L

Helicobacter pylori resistance in Southern Austria

Resch, A

Grading lymph node metastasis – a feasible approach for prognostication of stage III colorectal cancer patients

Resch, H

Pyoderma gangraenosum als seltene Komplikation eines M. Crohn

Pilotstudie: Knochendichte und Knochenmikroarchitektur bei Patienten mit Leberzirrhose

Sclerostin levels and changes in bone metabolism after bariatric surgery

Resch, M

Autoimmune gastritis is common in patients with iron deficiency – Non-invasive evaluation of iron deficiency aside guideline recommendations

Riedl, F

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Rieger, A

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Ritter, M

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Ritthaler, L

Erste Erfahrungen mit einer interdisziplinären Station für chronisch entzündliche Darmerkrankungen

Ryan, R

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Sallinger, D

Endoscopists with lowest sedation rates detect more colorectal adenomas in colonoscopy than those most frequently using sedation

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Low ADR is associated with poor adherence to post polypectomy surveillance guidelines

Salzl, P

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Sanai, F

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Sanin, M

Tako Tsubo Kardiomyopathie unter TNF alpha Therapie

Sarrazin, C

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Scarpignato, C

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Schaefer, B

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Schäfer, M

Long-term outcome of TNFα antibody treatment in patients with IBD: a retrospective single center study over 14 years

Scharnagl, H

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Scheiner, B

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

Schicho, R

DP2 Rezeptor-Antagonismus schützt vor entzündlichen Darmerkrankungen: proinflammatorische Rolle von Eosinophilen

Schlag, M

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

Schleicher, M

Efficacy of interferon-free all-oral regimens in the treatment of chronic Hepatitis C outside from clinical trials – a “real life experience”

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Access to reimbursement of interferon-free all-oral regimens for patients with chronic Hepatitis C in Austria

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Schmerboeck, B

Endotoxinmessung bei Leberzirrhose: Ein Methodenvergleich

Schmidt, A

Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C virus

Schneeberger, S

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Schneider, G

Retrospektive Outcomeanalyse von Colitis ulcerosa (CU) Patienten mit schwerem, steroidrefraktärem Schub

Schneider, W

Helicobacter pylori resistance in Southern Austria

Schöfl, R

Retrospektive Outcomeanalyse von Colitis ulcerosa (CU) Patienten mit schwerem, steroidrefraktärem Schub

Schöniger-Hekele, M

Endoscopic unroofing is effective for diagnosis and therapy of gastric submucosal tumors: A retrospective study including follow-up

Schubert, TL

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

Schulz-Knappe, P

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Schütz, A

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Schwabl, P

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Interferon-free regimens overcome the effect of portal hypertension on virologic response

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Schwaighofer, H

Liefert die Aspiration von Galle bei der ERCP einen Mikrobiologisch & Klinisch validen Befund?

Schwarzer, R

Interferon-free regimens overcome the effect of portal hypertension on virologic response

Seidl, M

Fokale Läsionen bei Barrettösophagus: Ergebnisse endoskopischer Interventionen im KH St. Elisabeth

Seifert, H

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Semlitsch, G

Helicobacter pylori resistance in Southern Austria

Sern, R

Efficacy and safety of IFN-free antiviral therapy in patients with HCV recurrence after liver transplantation: real-life experience from Austria

Sieghart, W

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Efficacy of transjugular intrahepatic portosystemic shunts (TIPS) for controlling variceal bleeding in patients with cirrhosis and portal hypertension

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

A new algorithm for predicting the hepatocellular carcinoma occurrence in cirrhotic patients

Short-term complications after TIPS-implantation in patients with liver cirrhosis and portal hypertension

Silbert, D

Seneszenzstimuli und Hypoxie induzieren LOXL2 und HIF1alpha Expression und führen zur Repression von E-Cadherin in Gallengangsepithelzellen

Sinnitsch, A

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Sipos, B

Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors – A TMA based Study

Smolle, E

Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors – A TMA based Study

Sourij, H

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Spindelböck, W

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Spindelboeck, W

Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Serum bile acids in cirrhosis depend on aetiology

Stadlbauer, V

Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF

Endotoxinmessung bei Leberzirrhose: Ein Methodenvergleich

Serum bile acids in cirrhosis depend on aetiology

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Stadlmayr, A

Natural course of subjects with elevated liver enzymes and normal liver histology

A distinct profile of Lyso-Phosphatidylcholines and amino acids characterizes NAFLD in lean subjects

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Dimethylarginine serum concentrations effectively identify subjects with colorectal carcinoma

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Parathyroid hormone is related to dysplasia and a higher rate of distal colorectal adenoma in women

Stainer, W

Tako Tsubo Kardiomyopathie unter TNF alpha Therapie

Stančić, A

DP2 Rezeptor-Antagonismus schützt vor entzündlichen Darmerkrankungen: proinflammatorische Rolle von Eosinophilen

Stättermayer, A

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Stättermayer, AF

Interferon-free regimens overcome the effect of portal hypertension on virologic response

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Usefulness of interferon Lambda-4, HLA Class II Polymorphysims and Killer-Immunglobuline-Like Recptor-2DL3:C1/C1 to predict spontaneous clearance of acute Hepatitis C virus infection

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Stauber, R

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Stauber, RE

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Serum bile acids in cirrhosis depend on aetiology

Staufer, K

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Stechemesser, L

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Steinacher, D

NorUDCA improves liver injury and glucose sensitivity in a mouse model of obesity and steatosis

Steindl-Munda, P

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Steiner, E

The relationship between gastric emptying and the postprandial exocrine pancreatic function measured by 11C-methionine PET-CT.

Steiner, H

Resistenzbestimmung bei Helicobacter-Pylori im Rahmen durchgeführter Gastroskopien im LK Amstetten in den Jahren von 2009 bis 2014

Steiner, P

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Steiner, S

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Steinle, H

Liefert die Aspiration von Galle bei der ERCP einen Mikrobiologisch & Klinisch validen Befund?

Stepan, V

Helicobacter pylori resistance in Southern Austria

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Stern, R

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Stiegler, P

Serum bile acids in cirrhosis depend on aetiology

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Stift, J

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Stimakovits, J

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Stojakovic, T

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing Cholangitis

Serum bile acids in cirrhosis depend on aetiology

NorUDCA improves liver injury and glucose sensitivity in a mouse model of obesity and steatosis

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Stolba, R

Carbohydrate malabsorption and carbohydrate-specific small intestinal bacterial overgrowth: diagnostic approach and overlap

Strasser, M

Natural course of subjects with elevated liver enzymes and normal liver histology

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Strassl, R

High prevalence of Vitamin D deficiency in patients with autoimmune Hepatitis: impact on clinical presentation and response to treatment

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

Real life experience with Interferon/Ribavirin-free antiviral treatment in renal transplant recipients and endstage renal disease-patients on dialysis infected with Hepatitis C virus

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Strobel, B

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Sturm, EM

DP2 Rezeptor-Antagonismus schützt vor entzündlichen Darmerkrankungen: proinflammatorische Rolle von Eosinophilen

Supper, P

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Szönyi, M

Erste Erfahrungen mit einer interdisziplinären Station für chronisch entzündliche Darmerkrankungen

Szyszkowitz, A

How many patients undergoing surgery for perianal abscess or fistula receive a diagnosis of IBD during follow-up?

Tawdrous, M

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Thalhammer, M

Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors – A TMA based Study

Theek, C

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Theurl, I

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Tilg, H

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Lipocalin2 protects from severe inflammation in IL-10 knockout mice

Akkermansia muciniphila protects from experimental alcoholic liver disease

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Tinchon, C

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Toplak, H

Österreich-adaptierte FODMAP-arme Diät bei Reizdarmsyndrom: Pilotstudie

Toyonaga, T

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Trajanoski, S

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Trattnig, S

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Trauner, M

Autoantikörper – Signaturen zur non-invasiven Diagnostik der nicht-alkoholischen Fettlebererkrankung

Interferon and ribavirin-free therapy with sofosbuvir and daclatasvir in a real-life cohort of difficult-to-treat HIV/HCV-coinfected patients

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Interferon-free regimens overcome the effect of portal hypertension on virologic response

The presence of echocardiographic abnormalities increases mortality in patients with spontaneous bacterial peritonitis

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Seneszenzstimuli und Hypoxie induzieren LOXL2 und HIF1alpha Expression und führen zur Repression von E-Cadherin in Gallengangsepithelzellen

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Seroprevalence of Hepatitis E Virus in patients with Autoimmune Hepatitis

The presence of a PNPLA3 (rs738409) single nucleotide polymorphism (SNP) is not associated with increased risk for fibrosis, portal hypertension, and hepatic steatosis in HIV/HCV-coinfected patients

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

The soluble guanylyl cyclase stimulator riociguat reduces liver fibrosis and portal pressure in cirrhotic rats

Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber

Identifying the trigger matters – outcome of severe acute kidney injury in patients with cirrhosis and ascites

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Decrease in liver fibrosis after achieving SVR in patients with chronic Hepatitis C infection

Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing Cholangitis

Serum lipid parameters in patients with chronic hepatitis C during IFN-free treatment: effect of HCV genotype and cirrhosis

NorUDCA improves liver injury and glucose sensitivity in a mouse model of obesity and steatosis

Changes in renal function parameters during nucleos(t)ide analogues (NA) treatment in patients with chronic hepatitis B

Endoscopic unroofing is effective for diagnosis and therapy of gastric submucosal tumors: A retrospective study including follow-up

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Low ADR is associated with poor adherence to post polypectomy surveillance guidelines

Traussnigg, S

Disturbed energy metabolism and lipid profile after a 4 week high oral fructose challenge: potential role of bile acids?

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Tripolt, N

Influence of Lactobacillus casei Shirota supplementation, insulin resistance and diet on gut microbiota, gut permeability and bile acid profile in patients with metabolic syndrome

Tschann, P

Oesophagusperforation/-ruptur: Stentung als primäre Therapieoption

Uraoka, T

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Vafai-Tabrizi, F

Azathioprine versus Mycophenolate Mofetil in combination with anti-TNF alpha agents in the management of Crohn's Disease

Valkovič, L

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Van Dooren, G

Shortening overall treatment to 12 weeks of Simeprevir (SMV) plus PEG-IFN/RBV in treatment-naïve chronic Hepatitis C (CHC) Genotype 1 patients: assessment of baseline and week 2 on-treatment predictors of SVR

Shortening overall treatment to 12 weeks of SIMEPREVIR plus pegylated-interferon/ribavirin according to early virologic response in treatment-naïve patients with chronic HCV genotype 4 infection and mild-to-moderate fibrosis

van Zijl, F

INSIGHT-Studie Österreich: Outcome – Daten zur Therapie des hepatozellulären Karzinoms (HCC) mit Sorafenib

Veits, L

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Vikoler, A

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Viveiros, A

Transferrin als unabhängiger Prädiktor für das Überleben bei Patienten mit Leberzirrhose

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Vogel, W

Efficacy of Peginterferon plus Ribavirin in patients receiving Opioid substitution therapy – final results of the Austrian Peghope-study

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Efficacy and Safety of Telbivudine as First-Line Therapy in Patients With Compensated Chronic Hepatitis B

Liefert die Aspiration von Galle bei der ERCP einen Mikrobiologisch & Klinisch validen Befund?

Transferrin als unabhängiger Prädiktor für das Überleben bei Patienten mit Leberzirrhose

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Vogelsang, H

Azathioprine versus Mycophenolate Mofetil in combination with anti-TNF alpha agents in the management of Crohn's Disease

Wagner, A

Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Metabolomics profiling identifies long-chain phosphatidyl-cholines as a potential causative link between iron and insulin resistance in NAFLD

Selektive ultraschallgesteuerte percutane transhepatische Cholangiografie und Drainage

Wagner, L

Klinischer Vergleich der Detektionsrate der 360 ° Dünndarmkapsel mit front view Dünndarmkapsel- Systemen hinsichtlich Schleimhautläsionen bei M. Crohn und Eisenmangelanämie

Wagner, M

The FXR agonist PX20606 reduces liver damage, fibrosis and portal hypertension in cirrhotic rats

Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Wahlström, A

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Absence of BSEP/ABCB11 protects from cholestatic liver and bile duct injury in a mouse model of sclerosing Cholangitis

Wakolbinger, R

Pilotstudie: Knochendichte und Knochenmikroarchitektur bei Patienten mit Leberzirrhose

Waldhör, T

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Waldmann, E

Endoscopists with lowest sedation rates detect more colorectal adenomas in colonoscopy than those most frequently using sedation

Das männliche Geschlecht ist der stärkste Risikofaktor für kolorektale Läsionen

Low ADR is associated with poor adherence to post polypectomy surveillance guidelines

Wang, C

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Wang, J

Lipocalin2 protects from severe inflammation in IL-10 knockout mice

Gut microbiome development along the colorectal adenoma-carcinoma sequence

Wappl, M

Behandlung von Präkanzerosen und Frühkarzinomen des oberen Gastrointestinaltrakts mittels endoskopischer Submukosadissektion – Behandlungsergebnisse der letzten 5 Jahre im KH St. Elisabeth Wien

Weiss, G

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Wenzl, E

Oesophagusperforation/-ruptur: Stentung als primäre Therapieoption

Wenzl, H

Sicherheit der fäkalen Mikrobiota Transplantation (FMT) bei immunsupprimierten Patienten

Long-term outcome of TNFα antibody treatment in patients with IBD: a retrospective single center study over 14 years

Complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease – preliminary results of a multicenter study of the Austrian IBD study group

Häufigkeit und Differentialdiagnosen einer erhöhten alkalischen Phosphatase bei PatientInnen mit CED an der Universitätsklinik für Innere Medizin Graz

Loss of Response to TNF-α blockers is associated with Levels of Drug and Antidrug Antibodies in IBD patients

Wenzl, HH

How many patients undergoing surgery for perianal abscess or fistula receive a diagnosis of IBD during follow-up?

Wewalka, F

Retrospektive Outcomeanalyse von Colitis ulcerosa (CU) Patienten mit schwerem, steroidrefraktärem Schub

Wieser, V

Restoration of low adipose PNPLA3 concentrations after bariatric surgery

Akkermansia muciniphila protects from experimental alcoholic liver disease

Wilhelmer, P

Differentielle Effekte von Gallensäuren auf Tubulus- und Sammelrohrepithelzellen

Winna, V

Behandlung von Präkanzerosen und Frühkarzinomen des oberen Gastrointestinaltrakts mittels endoskopischer Submukosadissektion – Behandlungsergebnisse der letzten 5 Jahre im KH St. Elisabeth Wien

Wolkersdörfer, G

Das Bouveret-Syndrom als seltene Ursache eines Gastric-outlet-Syndroms

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Wolkersdörfer, GW

Selektive ultraschallgesteuerte percutane transhepatische Cholangiografie und Drainage

Wrba, F

Impact of SNP rs2187668 in HLA-DQA1 on clinical presentation and treatment response in patients with type-1 autoimmune hepatitis

Ultra-high-field MR-spectroscopy in NAFLD as in-vivo tool for monitoring changes in fat and energy metabolism with potential identification of NASH and advanced fibrosis by saturation transfer technique

Endoscopic unroofing is effective for diagnosis and therapy of gastric submucosal tumors: A retrospective study including follow-up

Wurm, P

Morbus Whipple: Aktuelle Aspekte anhand eines Fallberichts

Fäkale Microbiota Transplantation bei fulminanter Clostridium difficile Infektion als Alternative zur Notfallskolektomie – eine Fallserie

Yahagi, N

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Zacherl, J

Transorale Schwellenspaltung bei Zenker'schem Hypopharynxdivertikel

Zeitlinger, M

A double-blind, randomized, placebo-controlled video capsule endoscopy trial on the safety and efficacy of Rifaximin-EIR 800 mg BID to prevent intestinal injury caused by a two-weeks-treatment of diclofenac SR 75 mg BID plus omeprazole 20 mg OD in 60 healthy volunteers

Zenz, C

How many patients undergoing surgery for perianal abscess or fistula receive a diagnosis of IBD during follow-up?

Ziachehabi, A

Endoscopic Submucosal Dissection (ESD) unter Tutoring durch Experten

Zöhrer, E

Serum bile acids in adolescents with type 1 diabetes: a new marker for glycaemic control?

Loss of Response to TNF-α blockers is associated with Levels of Drug and Antidrug Antibodies in IBD patients

Zoller, H

Safety and efficacy of Interferon//Ribavirin free therapy in Septuagenerians and Octogenerians with chronic Hepatitis C

Liefert die Aspiration von Galle bei der ERCP einen Mikrobiologisch & Klinisch validen Befund?

Transferrin als unabhängiger Prädiktor für das Überleben bei Patienten mit Leberzirrhose

Exzellentes Langzeitüberleben nach Lebertransplantation bei Patienten mit BCLC Intermediate Stage B Hepatozellulärem Karzinom und Ansprechen auf neoadjuvante Therapie

Interferon-free Sofosbuvir containing treatment regimens in a real-life cohort of chronic Hepatitis C patients with cirrhosis

Functional and clinical implications of ferroportin mutation p.Arg178Gln

Impaired Hepcidin Expression in Alpha-1-Antitrypsin Deficiency Causes Iron Overload and Cirrhosis

Zollner, G

Entzündlicher IgG4-positiver Pseudotumor der Lunge bei primär sklerosierender Cholangitis (PSC)

Serum bile acids in cirrhosis depend on aetiology

Proximal Selektive Vagotomie in Mdr2 Genknockout Mäusen führt zu einer Verminderung der Cholestase, des Leberschadens und zur Verringerung der duktularen Proliferation

Zollner-Schwetz, I

Helicobacter pylori resistance in Southern Austria

Österreicher, CH

Inhibition of intestinal bile acid absorption by ASBT inhibitor A4250 protects against cholestatic liver and bile duct injury in MDR2-/- mouse model of sclerosing Cholangitis

Öttl, K

Humanes Non-Mercaptalbumin: methodischer Aspekt eines Prognosemarkers bei ACLF